EHA 2020 | UKALL2011: ABL-class fusions & TKIs

Name: UKALL2011: ABL-class fusions & TKIs
Uploaded: 2020-06-22T00:00:00Z
Duration: 5 min 13 s
Description: Anthony Moorman, PhD, Newcastle University, Newcastle, UK discusses preliminary data from UKALL2011, focussing on ABL-class fusion acute lymphoblastic leukemia (ALL) and the use of tyrosine kinase inhibitors (TKIs). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Anthony Moorman • 22 Jun 2020

EHA 2020

Acute Lymphoblastic Leukemia Leukemia Imatinib

ALLTogether1 UKALL2011

Anthony Moorman, PhD, Newcastle University, Newcastle, UK discusses preliminary data from UKALL2011, focussing on ABL-class fusion acute lymphoblastic leukemia (ALL) and the use of tyrosine kinase inhibitors (TKIs). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).